<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is characterized by <z:mp ids='MP_0005048'>thrombosis</z:mp> (venous and arterial) and pregnancy loss in conjunction with the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, IgG or IgM anticardiolipin, or IgG or IgM anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I </plain></SENT>
<SENT sid="1" pm="."><plain>In most series, only a minority of patients with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> develop a clinical manifestation </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A cross-sectional study of consecutive patients in the Hopkins <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> Center was performed </plain></SENT>
<SENT sid="3" pm="."><plain>Interviews were done and records were reviewed for the following variables: gender, ethnicity, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, cholesterol, smoking, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C, hormone replacement therapy/oral contraceptives, hereditary <z:hpo ids='HP_0100724'>thrombophilia</z:hpo>, anticardiolipin antibodies IgG, IgM and IgA, and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LAC) </plain></SENT>
<SENT sid="4" pm="."><plain>Our aim was to identify risk factors associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> and pregnancy loss in patients with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A total of 122 patients (84% female, 74% Caucasian) were studied </plain></SENT>
<SENT sid="6" pm="."><plain>Patients were divided into 3 groups: primary APS, APS associated with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, and patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> but no <z:mp ids='MP_0005048'>thrombosis</z:mp> or pregnancy loss </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0004936'>Venous thrombosis</z:hpo> was associated with high <z:chebi fb="4" ids="17855">triglycerides</z:chebi> (p=0.001), hereditary <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> (p=0.02), anticardiolipin antibodies IgG&gt;40 (p=0.04), and LAC (p=0.012) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002155'>Hypertriglyceridemia</z:hpo> was associated with a 6.4-fold increase, hereditary <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> with a 7.3-fold increase, and anticardiolipin IgG&gt;40 GPL with a 2.8-fold increase in the risk of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0004420'>Arterial thrombosis</z:hpo> was associated with <z:hpo ids='HP_0000822'>hypertension</z:hpo> (p=0.008) and elevated <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (p=0.044) </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000822'>Hypertension</z:hpo> was associated with a 2.4-fold increase in the risk of <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>No correlations were found for pregnancy loss </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: The frequency of <z:mp ids='MP_0005048'>thrombosis</z:mp> and pregnancy loss is greater in APS associated with SLE than in primary APS </plain></SENT>
<SENT sid="13" pm="."><plain>Risk factors differ for venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> in APS </plain></SENT>
<SENT sid="14" pm="."><plain>Treatment of <z:hpo ids='HP_0000822'>hypertension</z:hpo> may be the most important intervention to reduce <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="15" pm="."><plain>Elevated <z:chebi fb="4" ids="17855">triglycerides</z:chebi> are a major associate of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, but the benefit of treatment is not known </plain></SENT>
<SENT sid="16" pm="."><plain>Hereditary <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> is an associate of venous but not <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, making it cost-effective to investigate only in <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
</text></document>